XO1 ^Companies

XO1 Ltd is a virtual biotechnology company focused on developing ichorcumab, an anticoagulant drug. The company operates without physical offices or laboratory space, instead engaging contract research and development specialists in Europe and the US. This virtual model allows XO1 to control costs and maximize quality by selecting the most appropriate suppliers for each task. Recently, the company raised $11 million from Index Ventures to further develop ichorcumab, which has been hailed as the "holy grail" of anticoagulant drugs.